CH492713A - Process for the preparation of esters - Google Patents

Process for the preparation of esters

Info

Publication number
CH492713A
CH492713A CH342870A CH342870A CH492713A CH 492713 A CH492713 A CH 492713A CH 342870 A CH342870 A CH 342870A CH 342870 A CH342870 A CH 342870A CH 492713 A CH492713 A CH 492713A
Authority
CH
Switzerland
Prior art keywords
acid
carbon atoms
reaction
alcohol
carried out
Prior art date
Application number
CH342870A
Other languages
German (de)
Inventor
Doyle Peter
Joseph Stacey Gilbert
Original Assignee
Ici Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB54135/66A external-priority patent/GB1147068A/en
Application filed by Ici Ltd filed Critical Ici Ltd
Publication of CH492713A publication Critical patent/CH492713A/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/24Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D213/28Radicals substituted by singly-bound oxygen or sulphur atoms
    • C07D213/30Oxygen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/24Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D213/26Radicals substituted by halogen atoms or nitro radicals
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/24Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D213/54Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D213/55Acids; Esters
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/24Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D213/54Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D213/56Amides
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/24Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D213/54Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D213/57Nitriles
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/61Halogen atoms or nitro radicals
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/62Oxygen or sulfur atoms
    • C07D213/63One oxygen atom
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/78Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D213/79Acids; Esters
    • C07D213/80Acids; Esters in position 3
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/89Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members with hetero atoms directly attached to the ring nitrogen atom

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pyridine Compounds (AREA)

Description

  

      Verfahren    zur     Herstellung    von Estern    Die Erfindung betrifft ein Verfahren zur Herstellung  von neuen Estern, die entzündungshemmende, schmerz  stillende und antipyretische Eigenschaften haben und die  Konzentration von     Fibrinogen    sowie von Cholesterin  und/oder Triglyceriden im Blut herabzusetzen vermögen  und somit für die Behandlung oder Prophylaxe von     Ko-          ronararterienkrankheit    und Atherosklerose geeignet sind.  



  Gemäss der Erfindung werden Ester der Formel I  
EMI0001.0005     
    Das  in welcher X Wasserstoff oder einen Alkyl- oder     Alkoxy-          rest    mit höchstens 3 C-Atomen oder ein Halogenatom,  Y einen gegebenenfalls durch ein oder zwei Halogenato  me substituierten Phenylrest, R1 und R=, die einander  gleich oder voneinander verschieden sein können, je  Wasserstoff oder einen Alkylrest mit höchstens 3     C-Ato-          men    und R3 einen Alkylrest mit höchstens 5 C-Atomen  bedeuten und die Reste Y und -CR1R2-COOR3 nicht  an benachbarte C-Atome des Pyridinkerns gebunden  sind, hergestellt.  



  Zweckmässig kann X z.B. ein Wasserstoffatom, ein  Methyl- oder Methoxyradikal oder ein Chlor- oder Brom  atom darstellen.  



  Als Beispiele für das oder die Halogenatome, die  gegebenenfalls im Y-Radikal vorhanden sind, kann man  Fluor- Chlor- und Bromatome erwähnen. Die Verbin  dungen, bei denen das Y-Radikal einen oder zwei     Halo-          gensubstituenten    enthält, stellen bevorzugte Verbindun  gen dar, weil sie im allgemeinen aktiver sind, als die  entsprechenden unsubstituierten Phenylderivate.  



  Stellt R1 oder R2 ein Alkylradikal dar, so kann die  ses z.B. ein Methylradikal sein. Das Alkylradikal R3  kann z.B. das Methyl- oder Äthylradikal sein.    Als Salze der Pyridinderivate sind insbesondere die  pharmazeutisch zulässigen Säureadditionssalze, wie z.B.  Hydrochloride, Hydrobromide, Sulfate oder Phosphate,  geeignet.  



       erfindungsgemäss    Verfahren besteht darin, dass  man eine Pyridylalkancarbonsäure der Formel II  in welcher X, Y, R1 und R2 die obige Bedeutung be-  
EMI0001.0013     
    sitzen, A eine Carboxyl- oder funktionell abgewandelte  Carboxylgruppe bedeutet und die Reste Y und -CR1R2-A  nicht an benachbarte C-Atome des Pyridinkerns gebun  den sind, mit einem Alkohol der Formel R3OH, in wel  cher     R3    die obige Bedeutung besitzt, oder einem reak  tionsfähigen Derivat davon umsetzt.  



  Als Pyridylalkancarbonsäure mit funktionell abge  wandelter Carboxylgruppe können das entsprechende Ni  tril und Alkalimetallsalze eingesetzt werden.  



  Die Veresterung kann durch Reaktion der     Carbon-          säure    mit dem Alkohol R3OH in Gegenwart einer anor  ganischen Säure, z.B. Schwefelsäure, oder von     Dicyclo-          hexylcarbodiimid    durchgeführt werden. Die Reaktion  kann gegebenenfalls in einem organischen Lösungsmit  tel, z.B. Chloroform, durchgeführt und durch Wärme  zufuhr beschleunigt oder zum Abschluss gebracht wer  den.

   Andererseits kann die Veresterung durch Reak  tion der Carbonsäure mit einem dem Alkohol R3OH  entsprechenden     Diazoalkan,        z.B.        Diazomethan,    in einem  organischen Lösungsmittel,     z.B.    einem Gemisch von Me-      thanol und Äther, bewirkt werden. Oder aber die     Ver-          esterung    kann durch Reaktion eines Alkalimetallsalzes  der Carbonsäure mit einer Verbindung der Formel R3Hal,  wobei R3 ein Alkylradikal mit höchstens 5 C-Atomen  darstellt und Hal ein Halogenatom, z.B. ein Chlor- oder  Bromatom, darstellt, bewirkt werden. Diese Reaktion  kann gegebenenfalls in einem organischen Lösungsmit  tel, z.B.

   Dimethylformamid, durchgeführt und gegebe  nenfalls durch Wärmezufuhr     beschleunigt    oder zum  Abschluss gebracht werden. Die Reaktion des der     Car-          bonsäure    entsprechenden Nitrils mit dem Alkohol er  folgt in der Regel unter sauren Bedingungen, z.B. in  Gegenwart von Schwefelsäure; sie kann durch Wärme  zufuhr beschleunigt oder zum Abschluss gebracht wer  den.  



  Die als Ausgangsprodukte eingesetzten Verbindun  gen der Formel II können nach an sich bekannten Me  thoden hergestellt werden. Die Erfindung ist im fol  genden     anhand    von Ausführungsbeispielen näher er  läutert.    <I>Beispiel 1</I>  Es wurden 7 g     6-(4-Chlorphenyl)-2-methylpyrid-3-yles-          sigsäure    in 230 ml Methanol gelöst, und die Lösung wur  de langsam zu einer Lösung von 1,1 g Diazomethan in  700 ml Äther zugesetzt, wobei die Lösung auf 5 C wäh  rend der Zugabe gehalten wurde.

   Die Lösungsmittel  wurden unter vermindertem Druck abgedampft, und  der feste Rückstand wurde in 100 ml Äther gelöst und  die Lösung mit 80 ml einer 5%igen wässerigen     Natrium-          carbonatlösung    und dann mit 80 ml Wasser gewaschen.  Die ätherische Lösung wurde an wasserfreiem Natrium  sulfat getrocknet, worauf das Lösungsmittel abgedampft  wurde. Der Rückstand wurde aus Petroläther (Sdp.     60-          80 C)    umkristallisiert. Somit erhielt man     Methyl-6-(4-          chlorphenyl)-2-methylpyrid-3-ylacetat,    Smp. 75-76 C.

      <I>Beispiel 2</I>  Eine Suspension von 6 g     6-(4-Chlorphenyl)-2-cyano-          methylpyridin    in 26m1 trockenen Methanols wurde in  einem Eisbad auf 0 C gebracht. Dann wurden 17 g kon  zentrierter Schwefelsäure langsam hinzugegeben, und die  entstehende blassgelbe Lösung wurde 18 Stunden unter       Rückfluss    erhitzt. Das Reaktionsgemisch wurde zu 150 g  Eis zugegeben, und der     pH-Wert    der Lösung wurde  mit einer konzentrierten Ammoniumhydroxydlösung  (spez. Gew. 0,88) auf 8 gebracht. Die Lösung wurde  3mal mit 100 ml Äther extrahiert, und von den vereinig  ten ätherischen Extrakten wurde das Lösungsmittel ab  gedampft. Der feste Rückstand wurde aus Petroläther  (Sdp. 60-80 C) umkristallisiert.

   Somit erhielt man     Me-          thyl-6-(4-chlorphenyl)pyrid-2-ylacetat,    Smp. 45-46 C.  



  Die als Ausgangsstoff verwendete     Cyanomethylver-          bindung    wurde wie folgt erzeugt:  Eine Lösung von 21 g     6-(4-Chlorphenyl)-2-methylpy-          ridin    in 400 ml Chloroform wurde in einem Eisbad auf  0 C gebracht. Dann wurden 30,9 g     m-Chlorperbenzoe-          säure    der Lösung langsam, anteilweise zugegeben, und  die Lösung wurde 24 Stunden auf 0-4 C gehalten. Die  Chloroformlösung wurde mit 150 ml einer 15%igen wäs  serigen Kaliumcarbonatlösung geschüttelt, und festes     Ka-          liumcarbonat    wurde hinzugegeben, bis der pH-Wert  der wässerigen Schicht auf 9 gebracht wurde.

   Die Chlo  roformschicht wurde vom Gemisch abgetrennt und dann  getrocknet, worauf das Lösungsmittel abgedampft wur  de. Somit erhielt man unreines     6-(4-chlorphenyl)-2-me-          thylpyridin-N-oxyd.    Dieses kann durch Umkristallisie-    rung aus Petroläther (Sdp. 60-80 C) gereinigt werden und  hat dann einen Schmelzpunkt von 92-94 C.  



  Es wurden 25 g des unreinen N-Oxyds in 112 ml  Acetylchlorid gelöst, und die Mischung wurde 6 Stun  den unter Rückfluss erhitzt. Nach Abdampfung des  überschüssigen Acetylchlorids wurde der braune ölige  Rückstand, der hauptsächlich aus     2-Acetoxymethyl-6-          -(4-chlorphenyl)pyridin-hydrochlorid    und     2-Chlormethyl-          -6-(4-chlorphenyl)pyridin-hydrochlorid    bestand, in 350 ml  Methanol gelöst. Eine Lösung von 20 g Natriumhydroxyd  in 20 g Wasser wurde hinzugegeben, und die Mischung  wurde 2 Stunden auf Umgebungstemperatur gehalten.  Das Methanol wurde im Vakuum abgedampft und der  Rückstand mit Äther und Wasser gemischt. Die ätheri  sche Schicht wurde vom Gemisch abgetrennt, und der  Äther wurde abgedampft.

   Somit erhielt man eine Mi  schung aus 6-(4-Chlorphenyl)-2-hydroxymethylpyridin  und 2 Chlormethyl-6-(4-chlorphenyl)pyridin, die für die  nächste Stufe ausreichend rein war. Zu einer Lösung  von 22 g dieser Mischung in 300 ml trockenen     Äthy-          lendichlorids    wurden langsam 11 ml Thionylchlorid zu  gegeben, wobei die Temperatur des Reaktionsgemisches  nicht über 35-40 C steigen durfte. Die Suspension wurde  1,5 Stunden gerührt und dann filtriert. Somit erhielt man  2 - Chlormethyl- 6 - (4- chlorphenyl)pyridin - hydrochlorid.  Durch Umkristallisierung dieses Salzes aus Isopropanol  erhielt man die entsprechende Base, Smp. 110-111 C.    Es wurden 15 g     2-Chlormethyl-6-(4-chlorphenyl)py-          ridinhydrochlorid    in 150 ml Wasser gelöst.

   Der Lösung  wurden 4 g einer konzentrierten Ammoniumhydroxydlö  sung (spez. Gew. 0,88) zugesetzt, und die Mischung wur  de 3mal mit Chloroform extrahiert. Die vereinigten Chlo  roformextrakte wurden getrocknet und das Lösungs  mittel wurde abgedampft. Somit erhielt man     kristallför-          miges    2-Chlormethyl-6-(4-chlorphenyl)-pyridin. Dieser  Feststoff wurde in 230 ml trockenen Methanols gelöst,  worauf 6,6 g Natriumcyanin hinzugegeben wurden und  die Mischung 10 Stunden in einer Stickstoffatmosphäre  unter Rückfluss erhitzt wurde. Das Reaktionsgemisch  wurde abgekühlt und zur Trockne eingedampft, worauf  der Rückstand mit Äther und Wasser gemischt wurde.  Die organische Schicht wurde vom Gemisch abgetrennt,  und das Lösungsmittel wurde abgedampft.

   Der feste  Rückstand wurde in 200 ml Äther gelöst und die Lösung  durch 250 g neutraler Tonerde (Woelm'sche Korngrösse  1) durchgeleitet. Vom Eluat wurde das Lösungsmittel  abgedampft, und der Rückstand wurde aus einem Ge  misch aus Äthylacetat und Petroläther (Sdp. 60-80 C)  umkristallisiert. Somit erhielt man     6-(4-Chlorphenyl)-2-          cyanomethylpyridin,    Smp. 80-82 C.  



  <I>Beispiel 3</I>  Eine Lösung von 1,2 g     Dimethyl-&alpha;-methyl-&alpha;-[4-(4-          -chlorphenyl)-6-methoxypyrid-2-yl]malonat    in 12 ml einer  methanolischen 2n-Natriumhydroxydlösung wurde 1 Stun  de unter Rückfluss erhitzt und dann in Vakuum einge  dampft. Der Rückstand wurde in 12 ml Wasser gelöst.  Die klare Lösung wurde mit Eisessigsäure auf einen  pH-Wert von 5 gebracht und das Ganze mit Äthylacetat  extrahiert. Der Extrakt wurde getrocknet und einge  dampft. Der Rückstand wurde mit Petroläther (Sdp.     40-          60 C)    schnell trituriert, und die entstehende Mischung  wurde filtriert.

   Somit erhielt man     .a-[4-(4-Chlorphenyl)-          -6-methoxypyrid-2-yl]propionsäure,        Smp.    84-87 C mit       Zers.    Eine kleine Probe des bereits beschriebenen Aus  gangsproduktes (Säure) wurde mit     Diazomethan    ver-      estert. Somit erhielt man den Methylester, Smp. 65-67 C  [nach Umkristallisierung aus Petroläther (Sdp. 40-60 C)].  Beispiel 4  Es wurden 6 g     2-(4-Chlorphenyl)-4-cyanomethylpyri-          din    in 30 ml Methanol, das 9,3 ml konzentrierter Schwe  felsäure enthielt, gelöst und die blassgalbe Lösung wurde  24 Stunden unter Rückfluss erhitzt.

   Die Lösung wurde mit  150 g Eis vermengt, und der     pH-Wert    wurde mit 19 ml  einer wässerigen 18n-Ammoniaklösung auf 8 gebracht,  worauf der gewünschte Ester durch Extraktion mit Äther  isoliert wurde. Das Lösungsmittel wurde abgedampft, und  der Rückstand wurde aus Petroläther (Sdp. 40-60 C)  umkristallisiert. Somit erhielt man     Methyl-2-(4-chlorphe-          nyl)pyrid-4-ylacetat,    Smp. 48-49 C.  



  <I>Beispiel 5</I>  Es wurden 1,4g     2-(4-Chlorphenyl)-4-(a-cyanoisopro-          pyl)-pyridin    dadurch hydrolysiert, dass es mit     5n-Salz-          säure    behandelt wurde. Somit erhielt man     a-[2-(4-Chlor-          phenyl)pyrid-4-yl]isobuttersäure.    Eine Probe dieser Säu  re (0,58 g) wurde langsam zu einer gut gerührten Lö  sung von überschüssigem Diazomethan in 50 ml Äther  während 10 Minuten unter Eiskühlung     zugegeben.    Nach  Aufhören der Stickstoffentwicklung wurde das Lösungs  mittel in Vakuum abgedampft.

   Somit erhielt man     Me-          thyl-a-[2-(4-chlorphenyl)pyrid-4-yl]isobutyrat,    Smp.     71-          72 C,    nach Umkristallisierung aus Petroläther (Sdp.     40-          60 C).     



  Das als Ausgangsstoff verwendete     2-(4-Chlorphenyl)-          -4-(a-cyanoisopropyl)pyridin    wurde wie folgt dargestellt:  Es wurde 5,7 g 2-(4-Chlorphenyl)-4-cyanomethylpyridin  zu einer Natriumamidlösung, die durch Auflösung von  0,595 g Natrium in 240 ml flüssigen Ammoniaks erzeugt  wurde, zugegeben, und die Suspension wurde gerührt, bis  sich eine klare grüne Lösung ergab. Dann wurden 4,7 ml  Methyljodid mit einem Mal hinzugegeben, und die Lö  sung wurde 30 Minuten gerührt. Nach Abdampfung des  ganzen Ammoniaks wurde der feste Rückstand mit  Äther und einer gesättigten wässrigen Natriumchlorid  lösung gemischt. Die organische Phase wurde abge  trennt, und die wässerige Phase wurde noch 2mal mit  Äther extrahiert.

   Die zusammengefassten ätherischen  Extrakte und die organische Phase wurden eingedampft,  wobei sich eine Mischung von Nitrilen (5 g) ergab, die  durch Chromatographie auf neutraler Tonerde  (Woelm'sche Korngrösse 1; 200 g getrennt wurde. Durch  Elution mit Benzol erhielt man eine feste Fraktion (1,7 g),  die aus einem Gemisch aus Benzol und Petroläther (Sdp.  60-80 ) umkristallisiert wurde. Somit erhielt man     2-(4-          -Chlorphenyl)-4-(a.-cyanoisopropyl)pyridin,    Smp. 94     -          96 C.     



  <I>Beispiel 6</I>  Eine Suspension von 1,55 g     6-(4-Chlorphenyl)-2-me-          thylpyrid-3-ylessigsäure    und 0,498 g Natriumbicarbonat  in einem 1:1-Wasser/Methanol-Gemisch (15 ml) wurde  kräftig gerührt, bis das Brausen aufgehört hatte und eine  klare Lösung erzielt wurde. Die Lösungsmittel wurden  unter vermindertem Druck abgedampft, und das Natrium  salz wurde durch Zugabe und nachträgliche     Abdamp-          fung    von 25 ml Benzol getrocknet, wobei der letztere  Vorgang 3mal wiederholt wurde.

   Der wasserfreie weisse  Feststoff wurde in 15 ml von wasserfreiem     Dimethyl-          formamid    suspendiert, worauf 1 ml Äthylbromid hin  zugegeben wurde und die Mischung 18 Stunden bei  Raumtemperatur gerührt wurde. Der klaren Lösung wur-    den 75 ml Wasser zugesetzt, und das Ganze wurde 3mal  mit je 25 ml eines 1:1-Gemisches aus Äther und Pe  troläther (Sdp. 40-60 C) extrahiert. Die     zusammengefass-          ten    organischen Schichten wurden 2mal mit je 25 ml  Wasser gewaschen, an Magnesiumsulfat getrocknet und  in Vakuum eingedampft.

   Somit erhielt man 1,64 g     Äthyl-          -6-(4-chlorphenyl)-2-methylpyrid-3-ylacetat.    Dieses wur  de aus Petroläther umkristallisiert (Sdp. 40-60 C) um  kristallisiert, wobei sich feine weisse Nadeln mit Smp.  54-55 C ergaben.



      Process for the production of esters The invention relates to a process for the production of new esters which have anti-inflammatory, pain-relieving and antipyretic properties and are able to reduce the concentration of fibrinogen and of cholesterol and / or triglycerides in the blood and are therefore suitable for the treatment or prophylaxis of Ko - coronary artery disease and atherosclerosis are suitable.



  According to the invention, esters of the formula I
EMI0001.0005
    The one in which X is hydrogen or an alkyl or alkoxy radical with a maximum of 3 carbon atoms or a halogen atom, Y is a phenyl radical optionally substituted by one or two halogen atoms, R1 and R =, which can be the same or different from one another, each Hydrogen or an alkyl radical with a maximum of 3 carbon atoms and R3 denotes an alkyl radical with a maximum of 5 carbon atoms and the radicals Y and -CR1R2-COOR3 are not bonded to adjacent carbon atoms of the pyridine nucleus.



  Suitably, X can e.g. represent a hydrogen atom, a methyl or methoxy radical or a chlorine or bromine atom.



  As examples of the halogen atom or atoms which may be present in the Y radical, fluorine, chlorine and bromine atoms can be mentioned. The compounds in which the Y radical contains one or two halogen substituents are preferred compounds because they are generally more active than the corresponding unsubstituted phenyl derivatives.



  If R1 or R2 represents an alkyl radical, this can e.g. be a methyl radical. The alkyl radical R3 can e.g. be the methyl or ethyl radical. As salts of the pyridine derivatives, the pharmaceutically acceptable acid addition salts, such as e.g. Hydrochlorides, hydrobromides, sulfates or phosphates, are suitable.



       according to the invention is that a pyridylalkanecarboxylic acid of the formula II in which X, Y, R1 and R2 have the above meaning
EMI0001.0013
    sit, A is a carboxyl or functionally modified carboxyl group and the radicals Y and -CR1R2-A are not bound to adjacent carbon atoms of the pyridine nucleus, with an alcohol of the formula R3OH, in which R3 has the above meaning, or one reactive derivative thereof converts.



  The corresponding Ni trile and alkali metal salts can be used as the pyridylalkanecarboxylic acid with a functionally modified carboxyl group.



  The esterification can be carried out by reacting the carboxylic acid with the alcohol R3OH in the presence of an inorganic acid, e.g. Sulfuric acid, or of dicyclohexylcarbodiimide. The reaction can optionally be carried out in an organic solvent, e.g. Chloroform, carried out and accelerated or brought to completion by the addition of heat.

   On the other hand, the esterification can be carried out by the reaction of the carboxylic acid with a diazoalkane corresponding to the alcohol R3OH, e.g. Diazomethane, in an organic solvent, e.g. a mixture of methanol and ether. Or the esterification can be carried out by reacting an alkali metal salt of the carboxylic acid with a compound of the formula R3Hal, where R3 is an alkyl radical with at most 5 carbon atoms and Hal is a halogen atom, e.g. a chlorine or bromine atom. This reaction can optionally be carried out in an organic solvent, e.g.

   Dimethylformamide, carried out and, if necessary, accelerated or brought to a conclusion by supplying heat. The reaction of the nitrile corresponding to the carboxylic acid with the alcohol usually takes place under acidic conditions, e.g. in the presence of sulfuric acid; it can be accelerated or completed by adding heat.



  The compounds of the formula II used as starting materials can be prepared by methods known per se. The invention is explained in more detail in the fol lowing using exemplary embodiments. <I> Example 1 </I> 7 g of 6- (4-chlorophenyl) -2-methylpyrid-3-ylesetic acid were dissolved in 230 ml of methanol, and the solution was slowly turned into a solution of 1.1 g Diazomethane in 700 ml of ether was added, the solution being kept at 5 C during the addition.

   The solvents were evaporated off under reduced pressure and the solid residue was dissolved in 100 ml of ether and the solution was washed with 80 ml of a 5% aqueous sodium carbonate solution and then with 80 ml of water. The ethereal solution was dried over anhydrous sodium sulfate and the solvent was evaporated. The residue was recrystallized from petroleum ether (boiling point 60-80 ° C.). Thus methyl 6- (4-chlorophenyl) -2-methylpyrid-3-ylacetate was obtained, m.p. 75-76C.

      <I> Example 2 </I> A suspension of 6 g of 6- (4-chlorophenyl) -2-cyano-methylpyridine in 26 ml of dry methanol was brought to 0 ° C. in an ice bath. Then 17 g of concentrated sulfuric acid was slowly added and the resulting pale yellow solution was refluxed for 18 hours. The reaction mixture was added to 150 g of ice, and the pH of the solution was brought to 8 with a concentrated ammonium hydroxide solution (specific weight 0.88). The solution was extracted 3 times with 100 ml of ether, and the solvent was evaporated from the combined ethereal extracts. The solid residue was recrystallized from petroleum ether (boiling point 60-80 ° C.).

   This gave methyl 6- (4-chlorophenyl) pyrid-2-ylacetate, m.p. 45-46 C.



  The cyanomethyl compound used as starting material was produced as follows: A solution of 21 g of 6- (4-chlorophenyl) -2-methylpyridine in 400 ml of chloroform was brought to 0 ° C. in an ice bath. Then 30.9 g of m-chloroperbenzoic acid were slowly and partially added to the solution, and the solution was kept at 0-4 ° C. for 24 hours. The chloroform solution was shaken with 150 ml of a 15% aqueous potassium carbonate solution, and solid potassium carbonate was added until the pH of the aqueous layer was brought to 9.

   The chloroform layer was separated from the mixture and then dried, whereupon the solvent was evaporated. Thus, impure 6- (4-chlorophenyl) -2-methylpyridine-N-oxide was obtained. This can be purified by recrystallization from petroleum ether (b.p. 60-80 C) and then has a melting point of 92-94 C.



  25 g of the impure N-oxide were dissolved in 112 ml of acetyl chloride, and the mixture was refluxed for 6 hours. After evaporation of the excess acetyl chloride, the brown oily residue, which mainly consisted of 2-acetoxymethyl-6- (4-chlorophenyl) pyridine hydrochloride and 2-chloromethyl-6- (4-chlorophenyl) pyridine hydrochloride, was dissolved in 350 ml Dissolved methanol. A solution of 20 g sodium hydroxide in 20 g water was added and the mixture was kept at ambient temperature for 2 hours. The methanol was evaporated in vacuo and the residue mixed with ether and water. The ethereal layer was separated from the mixture and the ether was evaporated.

   This gave a mixture of 6- (4-chlorophenyl) -2-hydroxymethylpyridine and 2-chloromethyl-6- (4-chlorophenyl) pyridine, which was sufficiently pure for the next stage. 11 ml of thionyl chloride were slowly added to a solution of 22 g of this mixture in 300 ml of dry ethylene dichloride, the temperature of the reaction mixture not being allowed to rise above 35-40.degree. The suspension was stirred for 1.5 hours and then filtered. Thus 2-chloromethyl-6 - (4-chlorophenyl) pyridine hydrochloride was obtained. Recrystallization of this salt from isopropanol gave the corresponding base, mp 110-111 C. 15 g of 2-chloromethyl-6- (4-chlorophenyl) pyridine hydrochloride were dissolved in 150 ml of water.

   4 g of a concentrated ammonium hydroxide solution (specific weight 0.88) were added to the solution, and the mixture was extracted 3 times with chloroform. The combined chloroform extracts were dried and the solvent was evaporated. Thus, crystalline 2-chloromethyl-6- (4-chlorophenyl) pyridine was obtained. This solid was dissolved in 230 ml of dry methanol, whereupon 6.6 g of sodium cyanine was added and the mixture was refluxed for 10 hours in a nitrogen atmosphere. The reaction mixture was cooled and evaporated to dryness, whereupon the residue was mixed with ether and water. The organic layer was separated from the mixture and the solvent was evaporated.

   The solid residue was dissolved in 200 ml of ether and the solution was passed through 250 g of neutral clay (Woelm grain size 1). The solvent was evaporated from the eluate, and the residue was recrystallized from a mixture of ethyl acetate and petroleum ether (boiling point 60-80 ° C.). This gave 6- (4-chlorophenyl) -2-cyanomethylpyridine, m.p. 80-82 C.



  <I> Example 3 </I> A solution of 1.2 g of dimethyl-α-methyl-α - [4- (4-chlorophenyl) -6-methoxypyrid-2-yl] malonate in 12 ml of a methanolic 2N sodium hydroxide solution was refluxed for 1 hour and then evaporated in vacuo. The residue was dissolved in 12 ml of water. The clear solution was brought to pH 5 with glacial acetic acid and the whole was extracted with ethyl acetate. The extract was dried and evaporated. The residue was quickly triturated with petroleum ether (bp 40-60 ° C.) and the resulting mixture was filtered.

   This gave .a- [4- (4-chlorophenyl) - -6-methoxypyrid-2-yl] propionic acid, m.p. 84-87 ° C. with dec. A small sample of the starting product (acid) already described was esterified with diazomethane. The methyl ester was thus obtained, mp 65-67 ° C. [after recrystallization from petroleum ether (boiling point 40-60 ° C.)]. Example 4 6 g of 2- (4-chlorophenyl) -4-cyanomethylpyridine were dissolved in 30 ml of methanol containing 9.3 ml of concentrated sulfuric acid, and the pale yellow solution was refluxed for 24 hours.

   The solution was mixed with 150 g of ice and the pH was brought to 8 with 19 ml of an aqueous 18N ammonia solution, whereupon the desired ester was isolated by extraction with ether. The solvent was evaporated and the residue was recrystallized from petroleum ether (bp 40-60 ° C.). This gave methyl 2- (4-chlorophenyl) pyrid-4-ylacetate, m.p. 48-49 C.



  <I> Example 5 </I> 1.4 g of 2- (4-chlorophenyl) -4- (a-cyanoisopropyl) pyridine were hydrolyzed by treating it with 5N hydrochloric acid. Thus, a- [2- (4-chlorophenyl) pyrid-4-yl] isobutyric acid was obtained. A sample of this acid (0.58 g) was slowly added to a well-stirred solution of excess diazomethane in 50 ml of ether over 10 minutes while cooling with ice. After the evolution of nitrogen had ceased, the solvent was evaporated off in vacuo.

   This gave methyl a- [2- (4-chlorophenyl) pyrid-4-yl] isobutyrate, mp 71-72 ° C., after recrystallization from petroleum ether (boiling point 40-60 ° C.).



  The 2- (4-chlorophenyl) -4- (a-cyanoisopropyl) pyridine used as starting material was prepared as follows: 5.7 g of 2- (4-chlorophenyl) -4-cyanomethylpyridine were added to a sodium amide solution which, by dissolution of 0.595 g of sodium in 240 ml of liquid ammonia was added and the suspension was stirred until a clear green solution resulted. Then 4.7 ml of methyl iodide was added all at once and the solution was stirred for 30 minutes. After all the ammonia had evaporated, the solid residue was mixed with ether and a saturated aqueous sodium chloride solution. The organic phase was separated off, and the aqueous phase was extracted twice with ether.

   The combined ethereal extracts and the organic phase were evaporated to give a mixture of nitriles (5 g) which was separated by chromatography on neutral clay (Woelm grain size 1; 200 g. A solid fraction was obtained by elution with benzene (1.7 g) which was recrystallized from a mixture of benzene and petroleum ether (b.p. 60-80) to give 2- (4- chlorophenyl) -4- (a.-cyanoisopropyl) pyridine, m.p. 94 - 96 C.



  <I> Example 6 </I> A suspension of 1.55 g 6- (4-chlorophenyl) -2-methylpyrid-3-ylacetic acid and 0.498 g sodium bicarbonate in a 1: 1 water / methanol mixture (15 ml) was stirred vigorously until the effervescence had stopped and a clear solution was obtained. The solvents were evaporated off under reduced pressure, and the sodium salt was dried by adding and subsequent evaporation of 25 ml of benzene, the latter process being repeated 3 times.

   The anhydrous white solid was suspended in 15 ml of anhydrous dimethylformamide, whereupon 1 ml of ethyl bromide was added and the mixture was stirred at room temperature for 18 hours. 75 ml of water were added to the clear solution, and the whole thing was extracted 3 times with 25 ml each of a 1: 1 mixture of ether and petroleum ether (bp 40-60 ° C.). The combined organic layers were washed twice with 25 ml of water each time, dried over magnesium sulfate and evaporated in vacuo.

   Thus 1.64 g of ethyl 6- (4-chlorophenyl) -2-methylpyrid-3-ylacetate were obtained. This was recrystallized from petroleum ether (boiling point 40-60 ° C.) to crystallize, with fine white needles with melting point 54-55 ° C.

 

Claims (1)

PATENTANSPRUCH Verfahren zur Herstellung von Estern der Formel EMI0003.0034 in welcher X Wasserstoff oder einen Alkyl- oder Alkoxy- rest mit höchstens 3 C-Atomen oder ein Halogenatom, Y einen gegebenenfalls durch ein oder zwei Halogen atome substituierten Phenylrest, RÚ und Rê, die einander gleich oder voneinander verschieden sein können, je Was serstoff oder einen Alkylrest mit höchstens 3 C-Atomen und R3 einen Alkylrest mit höchstens 5 C-Atomen be deuten und die Reste Y und -CRÚRê-COOR nicht an benachbarte C-Atome des Pyridinkerns gebunden sind, dadurch gekennzeichnet, dass man eine Pyridylalkancar- bonsäure der Formel 2 EMI0003.0039 in welcher X, Y, RÚ und Rê die obige Bedeutung besit zen, PATENT CLAIM Process for the preparation of esters of the formula EMI0003.0034 in which X is hydrogen or an alkyl or alkoxy radical with at most 3 carbon atoms or a halogen atom, Y is a phenyl radical optionally substituted by one or two halogen atoms, RÚ and Rê, which can be identical to or different from one another, each hydrogen or an alkyl radical with a maximum of 3 carbon atoms and R3 an alkyl radical with a maximum of 5 carbon atoms and the radicals Y and -CRÚRê-COOR are not bonded to adjacent carbon atoms of the pyridine nucleus, characterized in that a pyridylalkanecarboxylic acid of formula 2 EMI0003.0039 in which X, Y, RÚ and Rê have the above meaning, A eine Carboxyl- oder funktionell abgewandelte Carboxylgruppe bedeutet und die Reste Y und -CRÚRê-A nicht an benachbarte C-Atome des Pyridinkerns gebun den sind, mit einem Alkohol der Formel R3 OH, in wel cher R3 die obige Bedeutung besitzt, oder einem reak tionsfähigen Derivat davon umsetzt. UNTERANSPRÜCHE 1. Verfahren nach Patentanspruch, dadurch gekenn zeichnet, dass als Pyridylalkancarbonsäure mit funktio nell abgewandelter Carboxylgruppe das entsprechende Nitril oder ein Alkalimetallsalz eingesetzt wird. 2. A denotes a carboxyl or functionally modified carboxyl group and the radicals Y and -CRÚRê-A are not bound to adjacent carbon atoms of the pyridine nucleus, with an alcohol of the formula R3 OH, in which R3 has the above meaning, or a reac convertible derivative thereof. SUBClaims 1. The method according to claim, characterized in that the corresponding nitrile or an alkali metal salt is used as the pyridylalkanecarboxylic acid with a functionally modified carboxyl group. 2. Verfahren nach Patentanspruch, dadurch gekenn zeichnet, dass die Umsetzung der Pyridylalkancarbon- säure mit dem Alkohol in Gegenwart von Dicyclohexyl- carbodümid oder einer anorganischen Säure durchge führt wird. 3. Verfahren nach Patentanspruch, dadurch gekenn zeichnet, dass die Umsetzung der Pyridylalkancarbon- säure mit einem dem Alkohol der Formel R30H ent- sprechenden Diazoalkan in einem organischen Lösungs mittel durchgeführt wird. Process according to claim, characterized in that the reaction of the pyridylalkanecarboxylic acid with the alcohol in the presence of dicyclohexylcarbodiimide or an inorganic acid is carried out. 3. The method according to claim, characterized in that the reaction of the pyridylalkanecarboxylic acid with a diazoalkane corresponding to the alcohol of the formula R30H is carried out in an organic solvent. 4. Verfahren nach Patentanspruch und Unteran spruch 1, dadurch gekennzeichnet, dass die Umsetzung eines Alkalimetallsalzes der Pyridylalkancarbonsäure mit einem dem Alkohol der Formel R 0H entsprechenden Halogenid durchgeführt wird. 5. Verfahren nach Patentanspruch und Unteran spruch 1, dadurch gekennzeichnet, dass die Umsetzung des Nitrils mit dem Alkohol unter sauren Bedingungen durchgeführt wird. 6. Verfahren nach Patentanspruch oder den Unteran sprüchen 2, 4 und 5, dadurch gekennzeichnet, dass die Umsetzung in einem organischen Lösungsmittel durch geführt und/oder durch Wärmezufuhr beschleunigt oder zum Abschluss gebracht wird. 4. The method according to claim and sub-claim 1, characterized in that the reaction of an alkali metal salt of pyridylalkanecarboxylic acid with a halide corresponding to the alcohol of the formula R 0H is carried out. 5. The method according to claim and sub-claim 1, characterized in that the reaction of the nitrile with the alcohol is carried out under acidic conditions. 6. The method according to claim or the subordinate claims 2, 4 and 5, characterized in that the reaction is carried out in an organic solvent and / or accelerated or brought to completion by supplying heat. 7. Verfahren nach Patentanspruch, dadurch gekenn zeichnet, dass man die Verfahrensprodukte in Salze, ins besondere in pharmazeutisch zulässige Säureadditions- salze, überführt. 7. The method according to claim, characterized in that the process products are converted into salts, in particular into pharmaceutically acceptable acid addition salts.
CH342870A 1966-12-02 1967-12-01 Process for the preparation of esters CH492713A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB54135/66A GB1147068A (en) 1966-12-02 1966-12-02 Phenyl-pyridine derivatives
CH1696967A CH492712A (en) 1966-12-02 1967-12-01 Process for the preparation of pyridine derivatives
US6140670A 1970-08-05 1970-08-05

Publications (1)

Publication Number Publication Date
CH492713A true CH492713A (en) 1970-06-30

Family

ID=27177545

Family Applications (1)

Application Number Title Priority Date Filing Date
CH342870A CH492713A (en) 1966-12-02 1967-12-01 Process for the preparation of esters

Country Status (1)

Country Link
CH (1) CH492713A (en)

Similar Documents

Publication Publication Date Title
DD139844A5 (en) METHOD FOR PRODUCING AN AZYLANILIDE
CH645625A5 (en) BENZOESAEUR DERIVATIVES, METHOD FOR THE PRODUCTION THEREOF AND MEDICINAL PRODUCTS CONTAINING THESE COMPOUNDS.
EP0039844A2 (en) Process for the preparation of O-substituted derivatives of (+)-cyanidan-3-ols
DE2655009C2 (en)
DE3850240T2 (en) Process for the preparation of O-carboxyarylimidazolinones.
DE2454619A1 (en) PROCESS FOR PRODUCING NEW HETEROCYCLIC COMPOUNDS
CH492713A (en) Process for the preparation of esters
DE1468890B1 (en) Process for the production of tetrahydroindane intermediates for steroid derivatives
AT202152B (en) Process for the preparation of new dimethylaminopropylidene thiaxanthenes.
DE2525962A1 (en) NEW HETEROCYCLIC COMPOUNDS, THEIR PRODUCTION AND USE
DE4001002A1 (en) PYRIDINE-2,4-AND 2,5-DICARBONSAEUREDI (NITROXYALKYL) AMIDES, METHOD FOR THE PRODUCTION AND USE THEREOF
DE69018619T2 (en) ALPHA, BETA-UNSATURATED KETONES AND KETOXIME DERIVATIVE.
DE2021747A1 (en) Process for the preparation of new heterocyclic compounds
AT278787B (en) PROCESS FOR THE PRODUCTION OF NEW CARBONIC ACIDS AND THEIR SALTS
AT215998B (en) Process for the preparation of new hydrazine derivatives
DE1493567C3 (en) Esters of alpha-alkylthyroxine derivatives and process for their preparation
AT364836B (en) METHOD FOR PRODUCING NEW O-SUBSTITUTED DERIVATIVES OF (+) - CYANIDAN-3-OLS AND THE SALTS THEREOF
DE1801312C (en) 2 (4 biphenylyloxy) -heptanoic acid, its alkali and alkaline earth salts and these compounds fertilize the medicinal products they contain
CH251023A (en) Process for the preparation of B-picolyl nicotinate.
DE931471C (en) Process for the production of new esters of the pyridine and piperidine series
DE2528070A1 (en) 9-THIA-, 9-OXOTHIA- AND 9-DIOXOTHIA- 11,12-SECOPROSTAGLANDINE
CH359703A (en) Process for the production of new piperidines
DE1470080A1 (en) 1-Lower-alkyl-5-nitroimidazole-2-carboxamides, a process for their preparation and their use as medicinal products
DE2320377A1 (en) NEW 1-ACYL HOMOPYRIMIDAZOLE DERIVATIVES AND PROCESS FOR THEIR PRODUCTION
CH501009A (en) 1-(5-nitro-2-thiazolyl)-2-oxo-imidazolidines - prepn

Legal Events

Date Code Title Description
PL Patent ceased